New hope in fight against deadly asbestos cancer
Disease control
Completed
This study tested whether adding an immunotherapy drug called durvalumab to standard chemotherapy helps people with advanced pleural mesothelioma live longer. Pleural mesothelioma is an aggressive cancer often linked to asbestos exposure, with limited treatment options. The trial…
Phase: PHASE3 • Sponsor: PrECOG, LLC. • Aim: Disease control
Last updated Mar 02, 2026 15:26 UTC